Eli Lilly to unveil 21 dermatology data presentations at Fall Clinical 2026
Eli Lilly will present 21 poster sessions at the Fall Clinical Dermatology Conference in Las Vegas from Oct 8‑11 2026. The set includes 13 EBGLYSS posters for moderate‑to‑severe atopic dermatitis, six on the combined use of Taltz and Zepbound for psoriasis and obesity, and long‑term Olumiant data in pediatric alopecia areata. Executive vice‑president Adrienne Brown highlighted the focus on durable disease control and reduced treatment burden.
Why it matters
The company notes the data could shape investor views on Lilly’s dermatology pipeline and product efficacy. New efficacy and safety signals may affect market expectations for the upcoming commercial rollout of EBGLYSS and related assets.
Key facts
- 1Lilly will present 21 data sets at the conference. prnewswire.com
- 213 poster presentations will focus on EBGLYSS for atopic dermatitis. prnewswire.com
- 3Six presentations will examine Taltz plus Zepbound in psoriasis and obesity. prnewswire.com
- 4The conference runs Oct 8‑11 2026 in Las Vegas. prnewswire.com
- 5EBGLYSS data will include pediatric patients as young as six months. rttnews.com
- 6Olumiant long‑term data will come from the Phase 3 BRAVE‑AA‑PEDS study in pediatric alopecia areata. rttnews.com
Summary written by AlphAI from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.